cGxP.wire https://validator.w3.org/feed/docs/rss2.html Genmab Reports Positive Phase 3 Petosemtamab Combination Results in Head and Neck Cancer HUTCHMED Receives FDA Orphan Drug Designation for Sovleplenib in Immune Thrombocytopenia Idorsia and Nxera Pharma Expand Partnership as Phase 3 Lucerastat Study Begins Monte Rosa Therapeutics Earns $37.5M Milestone as Novartis Starts Second Phase 2 Trial of MRT-6160 Roche Launches VENTANA BAP1 Test to Improve Differential Diagnosis of Mesothelioma Nxera Pharma Secures Exclusive Asia Pacific Rights to Fabry Disease Candidate Lucerastat Mineralys Therapeutics Publishes Phase 2 Explore-CKD Results Supporting Lorundrostat’s Potential in Kidney Disease Adagene and Incyte Initiate Combination Trial of Muzastotug for Colorectal Cancer Madrigal Pharmaceuticals to Present Extensive Rezdiffra Evidence at AASLD The Liver Meeting 2026 Calidi Biotherapeutics Presents Promising CLD-401 and In Situ T-Cell Engager Data at ESMO 2026 CAMP4 Therapeutics Receives EU Approval to Advance CMP-002 Phase 1/2 Trial for SYNGAP1-Related Disorder Natera Highlights Signatera’s Potential in Bladder Cancer at ESMO 2026 Nautilus Biotechnology Joins ARPA-H-Funded Consortium to Study Alzheimer’s Disease and Cancer LUNGevity Launches Multi-Year Small Cell Lung Cancer Program Henlius Reports Positive U.S. Trial Results for Serplulimab Carnyx Therapeutics Advances Oral Sleep Drug CNYX-005 Atrium Therapeutics Starts First PRKAG2 Syndrome Trial TuHURA Reports Early IFx-2.0 Responses With Keytruda Aclaris Therapeutics Reports Positive ATI-052 Phase 1b Results in Atopic Dermatitis and Asthma TJ Biopharma Starts Phase 1 Trial for Cancer Drug TJ-C64B Galderma Launches ALASTIN Eye Complex With TriHex+ Cullinan Therapeutics Advances Velinotamig for Autoimmune Cytopenias Neurocrine Sets New Health Benchmark for Tardive Dyskinesia Eisai Survey Reveals Chemotherapy Burden in Endometrial Cancer RiboScience Reports Survival Data for Cancer Drug RBS2418 Azitra Reports Anti-Wrinkle Results for ATR-COSF Skin Formula BreakBio Appoints Former FDA Chief Stephen Hahn as Advisor Insilico Medicine Reports 40% Response With AI Drug ISM6331! Abbott Launches OncoDetect Cancer Detection Test Acurex Biosciences Wins U.S. Patent for Tremor Drug CU-00048 Tonix Pharmaceuticals Reports Phase 3 Data Showing TONMYA® Improved Physical Symptoms and Functional Ability in Fibromyalgia Anixa Biosciences Completes Fifth Ovarian Cancer CAR-T Cohort Vantive Expands HomeAdvantage to Advance Home Dialysis Merck’s KEYTRUDA Monotherapy Reduces Risk of Disease Progression or Death by 43% in Advanced or Recurrent dMMR Endometrial Cancer Pfizer’s TALZENNA Plus XTANDI Receives FDA Approval for Earlier Treatment of Metastatic Prostate Cancer Aptar Pharma Acquires PULMOTREE to Expand Next-Generation Pulmonary Drug Delivery Capabilities Mirum Pharmaceuticals Reports Positive PROGRESS Study Results for ATEBRIOZ in Children with Fibrodysplasia Ossificans Progressiva Daiichi Sankyo and AstraZeneca Announce EU Approval of Enhertu® as Adjuvant Treatment for HER2-Positive Early Breast Cancer Purespring Therapeutics Advances PS-003 Kidney-Targeted Gene Therapy Towards Clinical Development for X-Linked Alport Syndrome Roche Receives CE Mark for cobas® smart e Immunoanalyser to Expand Decentralised Diagnostics Propanc Biopharma Reports PRP Reverses Chemotherapy Resistance in Preclinical Pancreatic Cancer Models Ambros Therapeutics Plans Interim Analysis of Phase 3 Neridronate Trial Following FDA Alignment Medicenna Reports Up to Fourfold Survival Extension With MDNA209 in Preclinical Autoimmune Disease Models 23andMe Analysis Finds Medically Actionable Genetic Results in 10.6% of Nearly 6 Million Participants Octane Biotech and Currus Biologics Automate CUR-001 CAR T-Cell Manufacturing Merck Reports 32% Lower Risk of Death With Sac-TMT in Advanced Endometrial Cancer Bayer Wins China Approval for Asundexian to Prevent Stroke Ascletis Submits FDA Application for Oral Obesity Drug ASC39 Innovent Advances Sintilimab Combination for Melanoma Review Lilly Reports Durable Olomorasib Activity in KRAS Lung Cancer